Showing results (181-190 of 597) with videos related to
Sort By:
Pageof 60
Cancer Diagnosis & Prognosis|April 11, 2022
Age-related Survival Outcomes for Pancreatic Cancer by AgeAli Abbaszadeh Kasbi, Mohammed Ali Ashary, Mizba Baksh, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Predictive Value of the Prognostic Nutritional Index in Neoadjuvant Chemoradiotherapy for Rectal CancerChika Mizutani, Nobuhisa Matsuhashi, Hiroyuki Tomita, et al.Cancer Diagnosis & Prognosis|January 5, 2026
Safety of Adjuvant Oral Uracil-Tegafur Therapy in Older Patients With Resected Non-small Cell Lung CancerYoshimasa Akiba, Yuya Iwata, Takahiro Ichino, et al.Cancer Diagnosis & Prognosis|January 5, 2026
Comparison of IO-IO and IO-TKI Treatment Outcomes in Metastatic Renal Cell Carcinoma: Influence of Metastatic Site CountHiroshi Kikuchi, Takahiro Osawa, Sei Naito, et al.Cancer Diagnosis & Prognosis|January 5, 2026
Surgical Outcomes and Diagnostic Concordance in Patients With Pancreatic Neuroendocrine Tumors Undergoing Pancreatectomy: A Retrospective Cohort StudyAtsushi Nanashima, Masahide Hiyoshi, Naoya Imamura, et al.Cancer Diagnosis & Prognosis|January 5, 2026
Usefulness of White Blood Cell Differential-based Indices in Patients With Extensive-stage Small Cell Lung CancerMakoto Nakao, Mamiko Kuriyama, Ryohei Gomyo, et al.Cancer Diagnosis & Prognosis|January 5, 2026
Severe Immune-related Adverse Events and Their Effect on Survival in Patients With Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint InhibitorsTakashi Nojiri, Akiisa Omura, Hiroshi Nishimura, et al.Cancer Diagnosis & Prognosis|January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal CellsByung Mo Kang, Qinghong Han, Shukuan Li, et al.Cancer Diagnosis & Prognosis|May 5, 2025
Recurrent Diffuse Neurofibroma of the Mandibular Anterior Lingual Alveolar Process Associated With Dental and Skeletal Changes in Neurofibromatosis Type 1Reinhard E Friedrich, Felix K Kohlrusch, Christian HagelCancer Diagnosis & Prognosis|May 5, 2025
Factors Influencing Severe Hematologic Toxicity Following Niraparib Therapy in Patients With Ovarian CancerMichio Kimura, Shiori Yamada, Rina Matsuyama, et al.Pageof 60